Neuroscience: Visual restoration with optogenetics
Current Biology · 2023
DOI: 10.1016/j.cub.2022.12.052 ↗Kurz gefasst
Kommentar in der Zeitschrift Current Biology, 2023. Verfasst von Miranda L Scalabrino und 1 weiteren Autor:innen. Beteiligte Einrichtung: Stein Eye Institute, Department of Ophthalmology, University of California, Los Angeles, CA 90095, USA. Hauptthemen laut MEDLINE: Retinal Degeneration, Neurosciences. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: NEI.
Abstract (Originalsprache)
Treating photoreceptor degenerative diseases is an exciting application of optogenetic technologies. However, there are significant challenges, such as producing normal visual signaling as the retina rewires in response to photoreceptor death. However, a new study shows remarkable functional stability in retinal circuits that can be engaged by optogenetics following photoreceptor loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Stein Eye Institute, Department of Ophthalmology, University of California, Los Angeles, CA 90095, USA.
- Stein Eye Institute, Department of Ophthalmology, University of California, Los Angeles, CA 90095, USA. Electronic address: gfield@mednet.ucla.edu.
Förderung
- NEI
Zitieren
APA
Scalabrino, M. L., & Field, G. D. (2023). Neuroscience: Visual restoration with optogenetics. Current Biology. https://doi.org/10.1016/j.cub.2022.12.052
Vancouver
Scalabrino ML, Field GD. Neuroscience: Visual restoration with optogenetics. Current Biology. 2023. doi:10.1016/j.cub.2022.12.052
BibTeX
@article{Scalabrino2023,
author = {Scalabrino, Miranda L and Field, Greg D},
title = {Neuroscience: Visual restoration with optogenetics},
journal = {Current Biology},
year = {2023},
doi = {10.1016/j.cub.2022.12.052}
}
EUVIMED